0 followers
Olaris aims to fundamentally change how diseases are diagnosed and treated. With their pioneering metabolomics platform and machine learning algorithms, they produce personalized “Biomarkers of Response” (BoR) to readily differentiate drug responders (R) from non-responders (NR).
Elizabeth O'Day
Gameto
4 followers
Synthekine
3 followers
Tango Therapeutics
2 followers
Caribou Biosciences
2 followers
Vera Therapeutics
2 followers
Neogene Therapeutics
2 followers
Kyverna Therapeutics
7 followers
Day One Biopharmaceuticals
1 follower
Apogee Therapeutics
1 follower
Cargo
1 follower
Aura Biosciences
1 follower
Explore companies